In a 32‑week pregnant woman with a posterior placenta measuring 5.5 cm thick and prominent lacunae, normal fetal growth and Doppler studies, and no change on 2‑week follow‑up, what is the most likely cause of these placental findings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Placental Lacunae in a Posterior Placenta: Likely Placenta Accreta Spectrum

The prominent placental lacunae in this 32-week pregnancy with a posterior placenta most likely represent placenta accreta spectrum (PAS), even though the normal Doppler parameters and stable appearance over 2 weeks are somewhat reassuring. 1

Understanding Placental Lacunae

Pathophysiology of Lacunae in PAS

  • Placental lacunae are sonolucent spaces within the placenta that result from exposure to high-velocity, pulsatile blood flow from the myometrium directly into placental tissue when normal decidualization fails. 1
  • Multiple, large, and irregular lacunae are the most strongly associated ultrasound finding for placenta accreta spectrum, with the highest sensitivity and positive predictive value when identified in the second trimester. 1
  • The presence of lacunae reflects abnormal trophoblast infiltration through a defective endometrial-myometrial interface, allowing maternal blood to pool in irregular spaces within the placenta. 1

Distinguishing PAS Lacunae from Benign Placental Lakes

  • The key distinction is that PAS-associated lacunae demonstrate turbulent blood flow on color Doppler, occur with loss of the retroplacental clear zone, show myometrial thickness <1 mm, and are associated with placenta previa or low-lying placenta. 2
  • Benign placental lakes are typically smaller, more uniform, and occur without the constellation of other PAS features. 2

Critical Diagnostic Challenge: Posterior Location

Why Posterior PAS Is Frequently Missed

  • Posterior placenta accreta spectrum has dramatically lower ultrasound sensitivity (0-42.4%) compared to anterior PAS, with only 52.4-62% of posterior PAS cases detected prenatally. 3, 4, 5
  • In one multicenter study, 70% of posterior PAS cases were not suspected antenatally because classic ultrasound signs (lacunae, hypervascularity, myometrial thinning, bridging vessels) were far less frequently visualized. 4
  • Posterior PAS was discovered only at delivery in 46.7% of cases in systematic review, compared to much higher detection rates for anterior disease. 5

Why Normal Doppler May Be Falsely Reassuring

  • The absence of hypervascularity at the bladder-wall interface is common in posterior PAS—none of the posterior cases in one systematic review showed this classic anterior PAS sign. 5
  • Normal Doppler parameters do not exclude PAS; clinical risk factors remain equally important predictors even when imaging appears normal. 1, 6

Risk Factor Assessment Is Essential

Evaluate for These High-Risk Features

  • Prior cesarean delivery combined with placenta previa or low-lying placenta (within 20 mm of the internal os) accounts for 49% of all PAS cases and >80% of confirmed accreta. 1, 6, 7
  • The risk escalates from 3% with placenta previa alone to 11% with one prior cesarean, 40% with two, 61% with three, and 67% with five or more cesareans. 6, 7
  • Prior uterine surgery with cavity entry (myomectomy, dilation and curettage) is present in 71-76% of posterior PAS cases and carries an odds ratio of approximately 2.8 for PAS. 7, 3, 5
  • Advanced maternal age ≥35 years, multiparity (present in 82.5% of posterior PAS), Asherman syndrome, and in-vitro fertilization are additional independent risk factors. 6, 7, 5

Placental Thickness Consideration

  • The 5.5 cm placental thickness is at the upper limit of normal for 32 weeks but is not a specific marker for PAS; however, increased thickness combined with grade 3 calcifications before 35 weeks would suggest placental dysfunction. 2

Recommended Management Algorithm

Immediate Actions

  1. Obtain a detailed surgical history focusing on prior cesarean deliveries, myomectomy with cavity entry, curettage procedures, and any other uterine surgery. 6, 7
  2. Perform a meticulous re-evaluation of the placental location relative to the internal cervical os—placenta previa is present in 92.8% of posterior PAS cases. 3, 5
  3. Reassess for additional ultrasound markers that may have been subtle:
    • Loss of the normal hypoechoic retroplacental clear zone (present in 41.1% of posterior PAS) 5
    • Myometrial thickness <1 mm (present in 4.4-70% depending on detection) 4, 5
    • Bladder-wall irregularity (present in 16.6% of posterior PAS) 5
    • Placental bulge or extension into/beyond the myometrium 1

If Risk Factors Are Present

  • Even with normal Doppler and stable appearance, the combination of prominent lacunae + posterior location + any prior uterine surgery mandates preparation for possible PAS at delivery. 6, 4, 5
  • Refer immediately to a Level III or IV maternal care facility with a multidisciplinary team including maternal-fetal medicine, experienced pelvic surgeons (gynecologic oncologists for suspected percreta), urologic surgeons, interventional radiologists, obstetric anesthesiologists, and a blood bank with massive-transfusion protocols. 1, 6
  • Plan cesarean delivery at 34+0 to 35+6 weeks gestation if PAS is suspected, because approximately 50% of women who remain pregnant beyond 36 weeks require emergent delivery for hemorrhage. 6

Surgical Preparation

  • The standard operative approach for confirmed PAS is cesarean hysterectomy with the placenta left in situ after fetal delivery; manual removal of the placenta is absolutely contraindicated because it precipitates catastrophic hemorrhage. 1, 6
  • Activate a massive transfusion protocol with packed red blood cells, fresh-frozen plasma, and platelets in a 1:1:1 to 1:2:4 ratio if hemorrhage occurs. 6

Key Clinical Pitfalls to Avoid

  • Do not be falsely reassured by normal Doppler or stable 2-week follow-up—posterior PAS has poor ultrasound sensitivity and may appear deceptively benign. 4, 5
  • Do not rely solely on imaging—the absence of ultrasound findings does not exclude PAS when clinical risk factors are present. 1, 6
  • Do not assume benign placental lakes—prominent lacunae in the setting of any prior uterine surgery or posterior low-lying placenta warrant high suspicion for PAS. 2, 5
  • Do not attempt manual placental removal at delivery if the placenta does not separate spontaneously—this is the most dangerous error and requires immediate multidisciplinary team activation. 1, 6

Prognostic Context

  • Posterior PAS has a lower rate of hysterectomy (48%) compared to anterior PAS (89%) and a higher rate of successful conservative management with balloon tamponade (52% vs. 17%), but this does not reduce the need for expert surgical planning. 3
  • When posterior PAS is diagnosed antenatally and managed at a referral center, outcomes are significantly better than when discovered unexpectedly at delivery. 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Placental Lakes and Their Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2021

Guideline

Placenta Accreta Spectrum – Evidence‑Based Clinical Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Risk Factors for Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a 32‑week pregnant woman with known placenta previa and mild vaginal bleeding, is the safest initial step to obtain a repeat obstetric ultrasound rather than proceeding directly to cesarean delivery?
What is the most appropriate next step in managing a 27-year-old woman at 32 weeks gestation (gestational age) presenting with painless, bright-red vaginal bleeding, normal blood pressure (BP), tachycardia (heart rate of 90 beats per minute), and normal respiratory rate (RR)?
In a 40-year-old woman at 32 weeks gestation with two prior cesarean deliveries, presenting with a brief episode of mild painless vaginal bleeding, ultrasound showing partial placenta previa, and a reactive cardiotocogram, what is the most appropriate management?
What is the most appropriate management for a patient at 35 weeks of gestation with complete placenta previa and painless vaginal bleeding who is hemodynamically stable?
What do I do if a patient with placenta previa (placenta covering the cervix) at 22 weeks gestation is hemorrhaging?
What are the common prerenal causes of acute kidney injury?
Can I share my CT (computed tomography) scan report for you to interpret?
In an adult on tirzepatide (GLP‑1/GIP receptor agonist) with rapid weight loss (~1 kg/week) taking levothyroxine (Synthroid) 50 µg daily and having normal thyroid‑stimulating hormone and normal free thyroxine, does the levothyroxine dose need adjustment?
After open fixation of a large medial‑facet osteochondral fragment with anatomic medial patellofemoral ligament (MPFL) reconstruction in an 18‑year‑old, should postoperative care use a hinged knee brace instead of a rigid immobilizer?
For a pediatric patient with severe impetigo and suspected methicillin‑resistant Staphylococcus aureus or beta‑lactam allergy, what is the recommended clindamycin dosage, treatment duration, and counseling points?
What does an International Prostate Symptom Score of 5.5 indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.